High-level expression of soluble human β-defensin-2 in Escherichia coli

Process Biochemistry

Volumn 39, Issue 12, 2004, Pages 2199-2205

  Peng, Li ^a   Xu, Zhinan ^a   Fang, Xiangming ^b   Wang, Fang ^a   Cen, Peilin ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Antimicrobial peptide; Human defensin 2; Optimization; Soluble protein

Indexed keywords

EXPONENTIAL GROWTH; FUSION PROTEINS;

DNA; ESCHERICHIA COLI; GENES; GROWTH KINETICS; MICROORGANISMS;

PROTEINS;

ESCHERICHIA COLI; VECTORS;

EID: 4344559551     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2003.11.011     Document Type: Article

References (20)

1. Ganz T., Selsted M.E., Lehrer R.I. Defensins. Eur. J. Haematol. 44:1990;1-8
2. Ganz T., Lehrer R.I. Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 10:1998;41-44
3. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., et al. β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 286:1999;525-528
4. Harder J., Bartels J., Christophers E., Schröder J.M. A peptide antibiotic from human skin. Nature. 387:1997;861
5. Schröder J.M., Harder J. Human Beta-defensin 2. Int. J. Biochem. Cell. Biol. 31:1999;645-651
6. Fang X.M., Peng L., Xu Z.N., Wu J.M., Cen P.L. Cloning and expression of human beta-defensin-2 gene in Escherichia coli. Prot. Pept. Lett. 9:2002;31-37
7. Davis G.D., Elisee C., Newham D.M., Harrison R.G. New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol. Bioeng. 65:1999;382-388
8. Lilie H., Schwarz E., Rudolph R. Advances in refolding of proteins produced in E. coli. Curr. Opin. Biotechnol. 9:1998;497-501
9. Xu Z., Cen P.L. Primary purification of co-expressed soluble and insoluble alpha-interferon 2b from recombinant E. coli. Chinese J. Chem. Eng. 10:2002;686-689
10. Piers K.L., Brown M.H., Hancock R.E.W. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene. 134:1993;7-13
11. Lee J.H., Kim J.H., Hwang S.W., Lee W.J., Yonn H.K., Lee H.S., et al. High-level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies. Biochem. Biophys. Res. Commun. 277:2000;575-580
12. LaVallie E.R., DiBlasio E.A., Kovacic S., Grant K.L., Schendel P.F., McCoy J.M. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Bio/Technology. 11:1993;187-193
13. LaVallie E.R., Lu Z., Diblasio-Smith E.A., Collins-Racie L.A., McCoy J.M. Thioredoxin as a fusion partner for production of soluble recombinant proteins in Escherichia coli. Meth. Enzymol. 326:2000;322-340
14. Symersky J., Novak J., McPherson D.T., DeLucas L., Mestecky J. Expression of the recombinant human immunoglobulin J chain in Escherichia coli. Mol. Immunol. 37:2000;133-140
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
16. Gupta J.C., Pandey G., Mukherjee K.J. Two-stage cultivation of recombinant Saccharomyces cerevisiae to enhance plasmid stability under non-selective conditions: experimental study and modeling. Enzyme Microb. Technol. 28:2001;89-99
17. Zhang Y.K., Li T.M., Liu J.J. Low temperature and glucose enhanced T7 RNA polymerase-based plasmid stability for increasing expression of glucagons-like peptide-2 in Escherichia coli. Prot. Express. Purif. 29:2003;132-139
18. SivaKesava S., Xu Z.N., Chen Y.H., Hackett J., Huang R.C., Lam E., et al. Production of excreted human epidermal growth factor (hEGF) by an efficient recombinant Escherichia coli system. Process Biochem. 34:1999;893-900
19. Xu Z.N., Gang L., Cen P.L., Wong W.K.R. Factors influencing secretive production of human epidermal growth factor (hEGF) with recombinant E. coli K12. Bioprocess Eng. 23:2000;669-674
20. Sambrook J, Russell DW. Molecular cloning: a laboratory manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press, 2001.